Table 1. Selected studies of the combined treatment of statins with fenofibrate in T2DM patients.

Legend: ^a Values express the increase or reduction versus baseline in the combination treatment, except otherwise mentioned. ^b p < 0.05 versus baseline. ^c p < 0.05 versus placebo. ^d p < 0.05 versus fibrate monotherapy. ^e p < 0.05 versus statin monotherapy. Abbreviations: T2DM - type 2 diabetes mellitus; LDL-C - low-density lipoprotein cholesterol; TC - total cholesterol; TG - triglycerides; HDL-C - high-density lipoprotein cholesterol; apo - apolipoprotein; Lp(a) - lipoprotein (a); PCSK9 - proprotein convertase subtilisin/kexin type 9; VLDL - very low-density lipoprotein; VLDL-C - VLDL cholesterol; hsCRP - high-sensitivity C-reactive protein; LpPLA₂ - lipoprotein-associated phospholipase A₂; IDL - intermediate-density lipoprotein; HbA1c - glycosylated hemoglobin; IAUC - incremental area under the curve; q.d./b.i.d./t.i.d - once/twice/three times daily.